Clinical Trial Update: The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction) [Phase 2]

View source ↗

Summary

Phase 2 trial update describing the long-term and short-term efficacy and safety of autologous bone marrow cell transplantation in patients experiencing a first…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Autologous bone marrow cell transplantation

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Vascular Diseases, Cardiovascular Diseases | Phase 2 | Status: UNKNOWN